Answers are grounded in this paper and cite their sources.
The bacteria Clostridium difficile (C. difficile) is one of the significant nosocomial pathogens frequently implicated with antibiotic associated diarrhea. Infection with C. difficile can result in asymptomatic colonization to spectrum of complications collectively known as C. difficile associated diseases. Since the dawn of its discovery, the C. difficile has been a subject of research with respect to its virulence characteristics and epidemiology. Once thought to be a normal flora of human, it was later identified as an enterotoxigenic bacteria. Subsequently, this bacteria emerged to be an important nosocomial agent affecting patients of old age. Recent reports indicate dramatic shift in the epidemiology of C. difficile. Some of the notable changes are increasing incidences of community acquired infections, development of resistance to wide spectrum of antibiotics, frequent recurrences, infections among young individuals without any exposure to common risk factors, etc. This paper reviews the literatures of past 25 years that enlighten the alarming raise and changing epidemiological features of this agent, so as to necessitate in-depth studies towards its prevention and control.
No takes yet. Share an insight, caveat, or question.
Thiyagarajan et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: